BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tian Y, Ding RY, Zhi YH, Guo RX, Wu SD. Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. World J Gastroenterol 2006; 12(3): 415-419 [PMID: 16489641 DOI: 10.3748/wjg.v12.i3.415]
URL: https://www.wjgnet.com/1007-9327/full/v12/i3/415.htm
Number Citing Articles
1
Kshitij Srivastava, Anvesha Srivastava, Balraj Mittal. Potential biomarkers in gallbladder cancer: present status and future directionsBiomarkers 2013; 18(1): 1 doi: 10.3109/1354750X.2012.717105
2
G. Karatzas, E. Misiakos. Liver and Biliary Tract Surgery2006; : 267 doi: 10.1007/978-3-211-49277-2_21
3
Jeremy L. Davis, T. Peter Kingham. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 786 doi: 10.1016/B978-0-323-34062-5.00049-2
4
Olca Basturk, Alton B. Farris, N. Volkan Adsay. Diagnostic Immunohistochemistry2011; : 541 doi: 10.1016/B978-1-4160-5766-6.00019-4
5
Weirong Chen, Ziqun Liao, Maogen Chen, Gaoyang Cai, Tinghan Li. Significance of extracellular signal-regulated kinase (ERK) in the development of rectal carcinomaThe Chinese-German Journal of Clinical Oncology 2008; 7(1): 27 doi: 10.1007/s10330-007-0127-z
6
Yu Xia, Zhenhua Du, Xinyan Wang, Xiuqin Li. Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study ofTP53Gene TherapyHuman Gene Therapy 2018; 29(2): 242 doi: 10.1089/hum.2017.206
7
Sameer Gupta, Sudeep Garg, Vijay Kumar, Arun Chaturvedi, Sanjeev Misra, Naseem Akhtar, Shiv Rajan, Jatinder Kaur, Manikandan Lakshmanan, Kavitha Jain. Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival?Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(4): 460 doi: 10.14701/ahbps.2020.24.4.460
8
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular updateHistopathology 2009; 55(2): 218 doi: 10.1111/j.1365-2559.2008.03192.x
9
Hilla Solomon, Shalom Madar, Varda Rotter. Mutant p53 gain of function is interwoven into the hallmarks of cancerThe Journal of Pathology 2011; 225(4): 475 doi: 10.1002/path.2988
10
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancerExpert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
11
Melanie B Thomas. Targeted therapies for cancer of the gallbladderCurrent Opinion in Gastroenterology 2008; 24(3): 372 doi: 10.1097/MOG.0b013e3282f6a7df
12
Li Chen, Yuan-Yuan Wu, Peigen Liu, Jianli Wang, Guilan Wang, Jin Qin, Jiaming Zhou, Jianwei Zhu. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cellsMedical Oncology 2011; 28(S1): 528 doi: 10.1007/s12032-010-9690-1
13
M Dong, X Li, L-J Hong, R Xie, H-L Zhao, K Li, H-H Wang, W-D Shin, H-J Shen. Advanced Malignant Pleural or Peritoneal Effusion in Patients Treated with Recombinant Adenovirus p53 Injection plus CisplatinJournal of International Medical Research 2008; 36(6): 1273 doi: 10.1177/147323000803600614
14
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapyCancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
15
David S. Klimstra, Olca Basturk. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 765 doi: 10.1016/B978-0-323-34062-5.00047-9
16
Melanie B. Thomas. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapyCritical Reviews in Oncology/Hematology 2007; 61(1): 44 doi: 10.1016/j.critrevonc.2006.07.006
17
Pablo Letelier, Patricia Garcia, Pamela Leal, Carmen Ili, Kurt Buchegger, Ismael Riquelme, Alejandra Sandoval, Oscar Tapia, Juan C. Roa. Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder CarcinomaApplied Immunohistochemistry & Molecular Morphology 2014; 22(7): 530 doi: 10.1097/PAI.0b013e3182a318a9
18
Priya Rupesh, Pandey Manoj, Shukla Vijay Kumar. Biomarkers in carcinoma of the gallbladderExpert Opinion on Medical Diagnostics 2008; 2(5): 511 doi: 10.1517/17530059.2.5.511
19
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 891 doi: 10.1007/978-1-4419-7107-4_61
20
Tian Tang, Duan-Lian Zhang. Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot techniqueOncology Letters 2017; 13(5): 2937 doi: 10.3892/ol.2017.5856
21
Kumudesh Mishra, Anu Behari, Vinay Kumar Kapoor, M. Salman Khan, Swayam Prakash, Suraksha Agrawal. Vascular endothelial growth factor single‐nucleotide polymorphism in gall bladder cancerJournal of Gastroenterology and Hepatology 2013; 28(10): 1678 doi: 10.1111/jgh.12343
22
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinomaWorld Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
23
T. Peter Kingham, Michael I. D’Angelica. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract2012; : 741 doi: 10.1016/B978-1-4377-1454-8.00049-7
24
Juan Carlos Roa, N. Volkan Adsay. Molecular Surgical Pathology2013; : 65 doi: 10.1007/978-1-4614-4900-3_4
25
Pooja Shukla, Kumudesh Mishra, Ratnakar Shukla, Ruchira Vishwakarma, Niraj Kumari, Narendra Krishnani, Anu Behari, Vinay K. Kapoor. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancerJournal of Cancer Research and Therapeutics 2024; 20(1): 349 doi: 10.4103/jcrt.jcrt_1473_22
26
Yoav Shetzer, Hilla Solomon, Gabriela Koifman, Alina Molchadsky, Stav Horesh, Varda Rotter. The paradigm of mutant p53-expressing cancer stem cells and drug resistanceCarcinogenesis 2014; 35(6): 1196 doi: 10.1093/carcin/bgu073
27
Anjali Singh, Pramod K. Mishra, Sundeep Singh Saluja, Majid A. Talikoti, Pawan Kirtani, Abul Kalam Najmi. Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian PatientsOncology 2016; 91(6): 354 doi: 10.1159/000450999
28
Shalom Madar, Einav Harel, Ido Goldstein, Yan Stein, Ira Kogan-Sakin, Iris Kamer, Hilla Solomon, Elya Dekel, Perry Tal, Naomi Goldfinger, Gilgi Friedlander, Varda Rotter, Joseph Alan Bauer. Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon BetaPLoS ONE 2013; 8(4): e61353 doi: 10.1371/journal.pone.0061353